Lucid Diagnostics Receivables

Lucid Diagnostics (LUCD) currently reports a receivables of $690K as of March 2026. That compares with $61M in the prior-year period — down 98.9% year over year. Use the charts on this page to explore Lucid Diagnostics's receivables history and peer comparisons.

Lucid Diagnostics's receivables decreased from $61M to $690K — a 98.9% year-over-year decrease (period ending March 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Lucid Diagnostics reported $690K in receivables as of March 2026. That compares with $61M in the prior-year period — down 98.9% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current receivables of $690K, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Lucid Diagnostics, and consider following LUCD for alerts when major investors trade the stock.